Literature DB >> 27304242

Update in Pulmonary Vascular Disease 2015.

Bradley A Maron1,2, Mark T Gladwin3, Marc A Simon4.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27304242      PMCID： PMC4910895          DOI： 10.1164/rccm.201601-0143UP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  69 in total

1.  The Diastolic Pressure Gradient Does Not-and Should Not-Predict Outcomes.

Authors:  Evan L Brittain; Tufik R Assad; Anna R Hemnes; John H Newman
Journal:  JACC Heart Fail       Date:  2015-10       Impact factor: 12.035

2.  Pulmonary Arterial Capacitance Is an Important Predictor of Mortality in Heart Failure With a Preserved Ejection Fraction.

Authors:  Nadine Al-Naamani; Ioana R Preston; Jessica K Paulus; Nicholas S Hill; Kari E Roberts
Journal:  JACC Heart Fail       Date:  2015-06       Impact factor: 12.035

3.  Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension.

Authors:  Ekkehard Grünig; Nicola Ehlken; Ardeschir Ghofrani; Gerd Staehler; F Joachim Meyer; Jana Juenger; Christian F Opitz; Hans Klose; Heinrike Wilkens; Stephan Rosenkranz; Horst Olschewski; Michael Halank
Journal:  Respiration       Date:  2011-02-09       Impact factor: 3.580

4.  Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.

Authors:  Nils P Nickel; Edda Spiekerkoetter; Mingxia Gu; Caiyun G Li; Hai Li; Mark Kaschwich; Isabel Diebold; Jan K Hennigs; Ki-Yoon Kim; Kazuya Miyagawa; Lingli Wang; Aiqin Cao; Silin Sa; Xinguo Jiang; Raymond W Stockstill; Mark R Nicolls; Roham T Zamanian; Richard D Bland; Marlene Rabinovitch
Journal:  Am J Respir Crit Care Med       Date:  2015-06-01       Impact factor: 21.405

5.  The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease.

Authors:  Emmanouil Tampakakis; Peter J Leary; Van N Selby; Teresa De Marco; Thomas P Cappola; G Michael Felker; Stuart D Russell; Edward K Kasper; Ryan J Tedford
Journal:  JACC Heart Fail       Date:  2014-11-12       Impact factor: 12.035

6.  Significance of echocardiographic assessment for right ventricular function after balloon pulmonary angioplasty in patients with chronic thromboembolic induced pulmonary hypertension.

Authors:  Toshimitsu Tsugu; Mitsushige Murata; Takashi Kawakami; Risako Yasuda; Hanako Tokuda; Yugo Minakata; Yuichi Tamura; Masaharu Kataoka; Kentaro Hayashida; Hikaru Tsuruta; Yuichiro Maekawa; Soushin Inoue; Keiichi Fukuda
Journal:  Am J Cardiol       Date:  2014-10-31       Impact factor: 2.778

7.  RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension.

Authors:  Rebecca R Vanderpool; Michael R Pinsky; Robert Naeije; Christopher Deible; Vijaya Kosaraju; Cheryl Bunner; Michael A Mathier; Joan Lacomis; Hunter C Champion; Marc A Simon
Journal:  Heart       Date:  2014-09-11       Impact factor: 5.994

8.  Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension.

Authors:  Nadine Al-Naamani; Harold I Palevsky; David J Lederer; Evelyn M Horn; Stephen C Mathai; Kari E Roberts; Russell P Tracy; Paul M Hassoun; Reda E Girgis; Daichi Shimbo; Wendy S Post; Steven M Kawut
Journal:  Ann Am Thorac Soc       Date:  2016-01

9.  Pulmonary vascular and right ventricular reserve in patients with normalized resting hemodynamics after pulmonary endarterectomy.

Authors:  Guido Claessen; Andre La Gerche; Steven Dymarkowski; Piet Claus; Marion Delcroix; Hein Heidbuchel
Journal:  J Am Heart Assoc       Date:  2015-03-23       Impact factor: 5.501

10.  Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.

Authors:  Lu Long; Mark L Ormiston; Xudong Yang; Mark Southwood; Stefan Gräf; Rajiv D Machado; Matthias Mueller; Bernd Kinzel; Lai Ming Yung; Janine M Wilkinson; Stephen D Moore; Kylie M Drake; Micheala A Aldred; Paul B Yu; Paul D Upton; Nicholas W Morrell
Journal:  Nat Med       Date:  2015-06-15       Impact factor: 53.440
View more
  2 in total

1.  Translational Advances in the Field of Pulmonary Hypertension Bench to Bedside: How Fundamental Discoveries in Science Are Advancing Our Understanding and Therapy of Pulmonary Arterial Hypertension.

Authors:  Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2017-01-01       Impact factor: 21.405

2.  AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension.

Authors:  Jiao Zhang; Jianjie Dong; Marcy Martin; Ming He; Brendan Gongol; Traci L Marin; Lili Chen; Xinxing Shi; Yanjun Yin; Fenqing Shang; Yan Wu; Hsi-Yuan Huang; Jin Zhang; Yu Zhang; Jian Kang; Esteban A Moya; Hsien-Da Huang; Frank L Powell; Zhen Chen; Patricia A Thistlethwaite; Zu-Yi Yuan; John Y-J Shyy
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.